Stay updated on BMN 111 in Achondroplasia Children Clinical Trial
Sign up to get notified when there's something new on the BMN 111 in Achondroplasia Children Clinical Trial page.

Latest updates to the BMN 111 in Achondroplasia Children Clinical Trial page
- Check3 days agoChange DetectedThe screenshots indicate only minor formatting adjustments with no substantive changes to the study record (criteria, endpoints, enrollment, or locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check10 days agoNo Change Detected
- Check32 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.SummaryDifference3%

- Check39 days agoChange DetectedAdded a new revision label v3.1.0 and removed several drug-safety and pharmaceutical topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision v3.0.2. The update shifts the page toward a release/versioning focus while narrowing drug-related content.SummaryDifference0.4%

- Check53 days agoChange DetectedThe page revision was updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.SummaryDifference0.2%

- Check60 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check67 days agoChange DetectedThe web page has been updated to include new drug information for Vosoritide and additional resources related to achondroplasia, while removing some previous location details and genetic resources. Notably, the facility name and location have been added, enhancing the page's relevance to users seeking information on this treatment.SummaryDifference11%

Stay in the know with updates to BMN 111 in Achondroplasia Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMN 111 in Achondroplasia Children Clinical Trial page.